Fingerprint
Dive into the research topics of 'Human anti-tumor necrosis factor monoclonal antibody (adalimumab) in Crohn's disease: The CLASSIC-I trial'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Human anti-tumor necrosis factor monoclonal antibody (adalimumab) in Crohn's disease: The CLASSIC-I trial
Stephen B. Hanauer*, William J. Sandborn, Paul Rutgeerts, Richard N. Fedorak, Milan Lukas, Donald Macintosh, Remo Panaccione, Douglas Wolf, Paul Pollack
*Corresponding author for this work
Research output: Contribution to journal › Article › peer-review
1436
Scopus
citations